by John Conrad | Dec 3, 2020 | Community News
Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announced it has established its U.S. headquarters in Chicago, today announced it has...
by John Conrad | Oct 14, 2020 | EDUCATE, Featured
Three-year, $2.7 million grant will support unique needs of children of active military personnel CHICAGO and EDWARDSVILLE, IL, October 14, 2020 – iBIO EDUCATE, dedicated to inspiring the next generation of innovators and helping restore America’s leadership in...
by John Conrad | Aug 26, 2020 | Policy News
iBIO joined with other life sciences state associations in a letter to Department of Health and Human Services Secretary Alex Azar voicing our concern with proposals that would allow the federal government to exercise “march-in rights” on innovative therapeutics or...
by John Conrad | Jul 30, 2020 | iBIO News
iBIO, the Illinois Biotechnology Innovation Organization, today announced the launch of Transform Illinois, its innovative new program to enhance pandemic preparedness and recovery, erase health equity barriers and continue to nurture the state’s life sciences...
by John Conrad | Apr 3, 2020 | COVID, iBIO News
Following the March 23rd launch of the iBIO COVID-19 PPE Response Fund, we are pleased to announce significant growth in the donation of funds and medical supplies from the life sciences community. Currently the fund has received more than $750,000 in cash...
